tirzepatide approval date GLP-1 Medications for Weight Loss: Semaglutide vs vs Retat – Revolution Health & Wellness FDA approves Lilly's Mounjaro™ (tirzepatide)

The 2 major incretins found in the body are gastric-inhibitory-polypeptide (GIP) and glucagon-like-peptide-1 (GLP-1) [2]

Glutathione cannot enter our cells, and any glutathione we consume, inject, inhale or whatever else creative marketing may claim, is just broken down outside the cell

Use of these therapies is voluntary and undertaken at your own discretion

Why Brand-Name Cant Match Price Structural Barriers: Public Company Obligations: Must maximize shareholder return Quarterly earnings pressure Executive compensation tied to profits Cant dramatically reduce price without stock impact Sunk Costs: Billions invested in development Need to recoup investment Justify to shareholders and board Complex Distribution System: PBMs demand rebates Wholesalers take cut Pharmacy margins Cant easily change system Market Dynamics: Limited competition (patent protection) Can charge premium prices Demand exceeds supply No pressure to reduce Eli Lilly unlikely to reduce tirzepatide prices significantly while patents protected

Each capsule contains 500mcg of BPC-157 and 500mcg of TB-500, for a total standardized research peptide blend of 1000mcg per capsule

, Mukherjee, S